Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Russian Direct Investment Fund is Russia’s sovereign wealth fund created in 2011 to make equity co‑investments in Russian companies alongside international investors; it is an investment vehicle, not a drug developer, and therefore has no therapeutic pipeline or clinical-stage assets of its own.[2][3][5][9][10]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Russian Direct Investment Fund.